Twice-daily dosing of esomeprazole effectively inhibits acid secretion in CYP2C19 rapid metabolisers compared with twice-daily omeprazole, rabeprazole or lansoprazole
Available in National Diet Library
Find on the publisher's website
国立国会図書館デジタルコレクション
Digital data available
Check on the publisher's website
DOI[10.1111/apt.12492]to the data of the same series
Search by Bookstore
Read this material in an accessible format.
Search by Bookstore
Read in Disability Resources
- Other Services
Bibliographic Record
You can check the details of this material, its authority (keywords that refer to materials on the same subject, author's name, etc.), etc.
- Material Type
- 博士論文
- Author/Editor
- 佐原, 秀
- Publication, Distribution, etc.
- Publication Date
- 2016
- Publication Date (W3CDTF)
- 2016
- Alternative Title
- CYP2C19のrapid metaboliser群において、エソメプラゾールの1日2回投与は、オメプラゾール、ラベプラゾール、ランソプラゾールの1日2回投与に比べ、より強力な胃酸分泌抑制効果を示す
- Degree grantor/type
- 浜松医科大学
- Date Granted
- 2016-03-14
- Date Granted (W3CDTF)
- 2016-03-14